 Connection
David Keller to Follow-Up Studies
This is a "connection" page, showing publications David Keller has written about Follow-Up Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.063 |
|
|
|
-
Bergman DA, Keller D, Kuo DZ, Lerner C, Mansour M, Stille C, Richardson T, Rodean J, Hudak M. Costs and Use for Children With Medical Complexity in a Care Management Program. Pediatrics. 2020 04; 145(4).
Score: 0.022
-
Young BE, Holwerda SW, Vranish JR, Keller DM, Fadel PJ. Sympathetic Transduction in Type 2 Diabetes Mellitus. Hypertension. 2019 07; 74(1):201-207.
Score: 0.021
-
Sopata M, Katz N, Carey W, Smith MD, Keller D, Verburg KM, West CR, Wolfram G, Brown MT. Efficacy and safety of tanezumab in the treatment of pain from bone metastases. Pain. 2015 Sep; 156(9):1703-1713.
Score: 0.016
-
Hoberman A, Chao HP, Keller DM, Hickey R, Davis HW, Ellis D. Prevalence of urinary tract infection in febrile infants. J Pediatr. 1993 Jul; 123(1):17-23.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|